Page last updated: 2024-08-21

cyclopentenone and 4-hydroxy-2-nonenal

cyclopentenone has been researched along with 4-hydroxy-2-nonenal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Uchida, K	1
Edes, K; Fitzpatrick, FA; Moos, PJ; Mullally, JE	1
Fitzpatrick, FA; Mullally, JE; Wagner, TM	1

Reviews

1 review(s) available for cyclopentenone and 4-hydroxy-2-nonenal

Article	Year
Cellular response to bioactive lipid peroxidation products. Free radical research, 2000, Volume: 33, Issue:6 Topics: Aldehydes; Animals; Cyclooxygenase 2; Cyclopentanes; Gene Expression; Glutathione Transferase; Humans; Isoenzymes; Lipid Peroxidation; Membrane Proteins; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Signal Transduction	2000

Other Studies

2 other study(ies) available for cyclopentenone and 4-hydroxy-2-nonenal

Article	Year
Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. The Journal of biological chemistry, 2001, Aug-10, Volume: 276, Issue:32 Topics: Aldehydes; Apoptosis; Biopolymers; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclopentanes; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Endopeptidases; Epitopes; Genes, p53; Humans; Immunohistochemistry; Ketones; Models, Biological; Models, Chemical; Multienzyme Complexes; Peptide Hydrolases; Phosphorylation; Polyubiquitin; Prostaglandins; Proteasome Endopeptidase Complex; Protein Binding; Protein Conformation; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ubiquitins	2001
Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translati The Journal of biological chemistry, 2006, Feb-03, Volume: 281, Issue:5 Topics: Aldehydes; AMP-Activated Protein Kinase Kinases; Cell Line, Tumor; Cyclooxygenase 2; Cyclopentanes; Energy Metabolism; Humans; Lipids; Mutagenesis, Site-Directed; Phosphotransferases (Phosphate Group Acceptor); Prostaglandins; Protein Biosynthesis; Protein Serine-Threonine Kinases	2006

Article

Year

Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.

The Journal of biological chemistry, 2001, Aug-10, Volume: 276, Issue:32

Topics: Aldehydes; Apoptosis; Biopolymers; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclopentanes; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Endopeptidases; Epitopes; Genes, p53; Humans; Immunohistochemistry; Ketones; Models, Biological; Models, Chemical; Multienzyme Complexes; Peptide Hydrolases; Phosphorylation; Polyubiquitin; Prostaglandins; Proteasome Endopeptidase Complex; Protein Binding; Protein Conformation; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ubiquitins

2001

Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translati

The Journal of biological chemistry, 2006, Feb-03, Volume: 281, Issue:5

Topics: Aldehydes; AMP-Activated Protein Kinase Kinases; Cell Line, Tumor; Cyclooxygenase 2; Cyclopentanes; Energy Metabolism; Humans; Lipids; Mutagenesis, Site-Directed; Phosphotransferases (Phosphate Group Acceptor); Prostaglandins; Protein Biosynthesis; Protein Serine-Threonine Kinases

2006